Home>Mutual Funds>Compare>Compare Nippon India Pharma Fund Direct Growth with SBI Healthcare Opportunities Fund Direct Plan Growth
shareSHARE
Compare Funds
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
cancel

Nippon India Pharma Fund Direct Growth

Equity
Sectoral / Thematic
5.0star
INVEST NOW
cancel

SBI Healthcare Opportunities Fund Direct Plan Growth

Equity
Sectoral / Thematic
3.0star
INVEST NOW
add_circle_outline

Add a fund

Nippon India Pharma Fund Direct Growth

(60.9%)

SBI Healthcare Opportunities Fund Direct Plan Growth

(58.1%)
1Y
3Y
5Y
Fund Details
keyboard_arrow_up
RiskVery HighVery High-
Min SIP Amount₹100₹500-
Expense Ratio1.16%1.06%-
NAV₹337.9 (26-Jul-2021)₹260.5 (26-Jul-2021)-
Fund Started01-Jan-201301-Jan-2013-
Fund Size₹5,447Cr₹2,004Cr-
Returns
keyboard_arrow_up
1Y
60.9%
58.1%
-
3Y
31.4%
29.2%
-
5Y
18.5%
11.9%
-
Pros & Cons
keyboard_arrow_up
Pros
1. 1Y Returns are higher than the category average returns
2. 3Y Returns are higher than the category average returns
3. 5Y Returns are higher than the category average returns
1. 1Y Returns are higher than the category average returns
2. 3Y Returns are higher than the category average returns
-
Cons
Found nothing so far.
1. 5Y Returns are lower than the category average returns
-

Holding Analysis

keyboard_arrow_up
Top 5
-
-
-
Top 20
-
-
-
P/E
-
-
-
P/B
-
-
-
Turnover
-
-
-
Equity
-
-
-
Cash
-
-
-

Top Holdings

keyboard_arrow_up
Top 10 Holdings
Name
Assets
Dr. Reddy's Laboratories Ltd.
9.6%
Divi's Laboratories Ltd.
9.3%
Sun Pharmaceutical Industries Ltd.
9.1%
Cipla Ltd.
8.6%
Aurobindo Pharma Ltd.
8.0%
Lupin Ltd.
7.2%
Gland Pharma Ltd.
6.6%
Fortis Healthcare Ltd.
5.5%
Cadila Healthcare Ltd.
4.7%
Apollo Hospitals Enterprise Ltd.
4.6%
Name
Assets
Dr. Reddy's Laboratories Ltd.
9.7%
Aurobindo Pharma Ltd.
9.5%
Sun Pharmaceutical Industries Ltd.
9.4%
Cipla Ltd.
8.7%
Divi's Laboratories Ltd.
7.9%
Lupin Ltd.
7.6%
Alkem Laboratories Ltd.
4.0%
Narayana Hrudayalaya Ltd.
3.7%
Apollo Hospitals Enterprise Ltd.
3.5%
Max Healthcare Institute Ltd.
3.4%
-
Fund Manager
keyboard_arrow_up
Name
Sailesh Raj Bhan
Tanmaya Desai
-
Education
Mr. Bhan is an MBA (Finance) and CFA.
Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).
-
Experience
Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.
Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
-
About Fund
keyboard_arrow_up
Description

Reliance Mutual Fund started their mutual fund on 30/06/1995 and its managing total assets of ₹2,32,169 Cr. Its ranked at 3 as per total assets at end of 30th Sep 2017.

SBI Mutual Fund started their mutual fund on 29/06/1987 and its managing total assets of ₹1,88,455 Cr. Its ranked at 5 as per total assets at end of 30th Sep 2017.

-

Launch Date

30 Jun 1995

29 Jun 1987

-

Custodian

Deutsche Bank

SBI SG Global Securities Services Pvt.Ltd.

-

Registrar & Transfer Agent

KFin Tech

Cams

-

Popular Comparisons

Motilal Oswal Multicap 35 Fund - Direct - Growth
VS
SBI Magnum Multi Cap Fund - Direct - Growth
Axis Bluechip Fund - Direct - Growth
VS
SBI Bluechip Fund - Direct - Growth
HDFC Small Cap Fund - Direct - Growth
VS
L&T Emerging Businesses Fund - Direct - Growth
ⓒ 2016-2021 Groww. All rights reserved, Built with in India